Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 182

1.

Lupus nephritis: maintenance therapy for lupus nephritis--do we now have a plan?

Lenz O, Waheed AA, Baig A, Pop A, Contreras G.

Clin J Am Soc Nephrol. 2013 Jan;8(1):162-71. doi: 10.2215/CJN.03640412. Epub 2012 Aug 23. Review.

2.
3.

Mycophenolate mofetil in induction and maintenance therapy of severe lupus nephritis: a meta-analysis of randomized controlled trials.

Zhu B, Chen N, Lin Y, Ren H, Zhang W, Wang W, Pan X, Yu H.

Nephrol Dial Transplant. 2007 Jul;22(7):1933-42. Epub 2007 Apr 3. Review.

PMID:
17405792
4.

Treatment for lupus nephritis.

Henderson L, Masson P, Craig JC, Flanc RS, Roberts MA, Strippoli GF, Webster AC.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD002922. doi: 10.1002/14651858.CD002922.pub3. Review.

PMID:
23235592
5.

Mycophenolate mofetil versus azathioprine as maintenance therapy for lupus nephritis: a meta-analysis.

Feng L, Deng J, Huo DM, Wu QY, Liao YH.

Nephrology (Carlton). 2013 Feb;18(2):104-10. doi: 10.1111/nep.12006. Review.

PMID:
23113811
6.

Induction and maintenance treatment of proliferative lupus nephritis: a meta-analysis of randomized controlled trials.

Henderson LK, Masson P, Craig JC, Roberts MA, Flanc RS, Strippoli GF, Webster AC.

Am J Kidney Dis. 2013 Jan;61(1):74-87. doi: 10.1053/j.ajkd.2012.08.041. Epub 2012 Nov 22.

PMID:
23182601
7.

What is the value of mycophenolate mofetil as induction and maintenance therapy in lupus nephritis?

Jones RB, Walsh M, Smith KG.

Curr Opin Rheumatol. 2009 May;21(3):256-61. Review.

PMID:
19399995
8.

Sequential therapies for proliferative lupus nephritis.

Contreras G, Pardo V, Leclercq B, Lenz O, Tozman E, O'Nan P, Roth D.

N Engl J Med. 2004 Mar 4;350(10):971-80.

9.

Comparison of Lupus Nephritis Induction Treatments in a Hispanic Population: A Single-center Cohort Analysis.

Mejía-Vilet JM, Arreola-Guerra JM, Córdova-Sánchez BM, Morales-Buenrostro LE, Uribe-Uribe NO, Correa-Rotter R.

J Rheumatol. 2015 Nov;42(11):2082-91. doi: 10.3899/jrheum.150395. Epub 2015 Sep 15.

PMID:
26373566
10.

Induction and maintenance therapy for lupus nephritis: a systematic review and meta-analysis.

Lee YH, Woo JH, Choi SJ, Ji JD, Song GG.

Lupus. 2010 May;19(6):703-10. doi: 10.1177/0961203309357763. Epub 2010 Jan 11. Review.

PMID:
20064907
11.

The use of low-dose cyclophosphamide followed by AZA/MMF treatment in childhood lupus nephritis.

Baskin E, Ozen S, Cakar N, Bayrakci US, Demirkaya E, Bakkaloglu A.

Pediatr Nephrol. 2010 Jan;25(1):111-7. doi: 10.1007/s00467-009-1291-x. Epub 2009 Sep 1.

PMID:
19727839
12.

Mycophenolate mofetil versus azathioprine in the maintenance therapy of lupus nephritis.

Sahin GM, Sahin S, Kiziltas S, Masatlioglu S, Oguz F, Ergin H.

Ren Fail. 2008;30(9):865-9. doi: 10.1080/08860220802353843.

PMID:
18925525
13.

Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial.

Houssiau FA, D'Cruz D, Sangle S, Remy P, Vasconcelos C, Petrovic R, Fiehn C, de Ramon Garrido E, Gilboe IM, Tektonidou M, Blockmans D, Ravelingien I, le Guern V, Depresseux G, Guillevin L, Cervera R; MAINTAIN Nephritis Trial Group.

Ann Rheum Dis. 2010 Dec;69(12):2083-9. doi: 10.1136/ard.2010.131995. Epub 2010 Sep 10.

14.

Mycophenolate mofetil for lupus nephritis: an update.

Mok CC.

Expert Rev Clin Immunol. 2015;11(12):1353-64. doi: 10.1586/1744666X.2015.1087314. Epub 2015 Sep 12. Review.

PMID:
26364748
15.

Lupus nephritis: induction therapy in severe lupus nephritis--should MMF be considered the drug of choice?

Rovin BH, Parikh SV, Hebert LA, Chan TM, Mok CC, Ginzler EM, Hooi LS, Brunetta P, Maciuca R, Solomons N.

Clin J Am Soc Nephrol. 2013 Jan;8(1):147-53. doi: 10.2215/CJN.03290412. Epub 2012 Aug 9. Review.

16.

Treatment of lupus nephritis.

Shum K, Askanase A.

Curr Rheumatol Rep. 2011 Aug;13(4):283-90. doi: 10.1007/s11926-011-0187-5. Review.

PMID:
21584691
17.

Defining the role of mycophenolate mofetil in the treatment of proliferative lupus nephritis.

Lenz O, Fornoni A, Contreras G.

Drugs. 2005;65(17):2429-36.

PMID:
16296869
18.

Mycophenolate mofetil as maintenance therapy for proliferative lupus nephritis: a long-term observational prospective study.

Laskari K, Mavragani CP, Tzioufas AG, Moutsopoulos HM.

Arthritis Res Ther. 2010;12(6):R208. doi: 10.1186/ar3184. Epub 2010 Nov 9.

19.

Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis.

Tamirou F, D'Cruz D, Sangle S, Remy P, Vasconcelos C, Fiehn C, Ayala Guttierez Mdel M, Gilboe IM, Tektonidou M, Blockmans D, Ravelingien I, le Guern V, Depresseux G, Guillevin L, Cervera R, Houssiau FA; MAINTAIN Nephritis Trial Group.

Ann Rheum Dis. 2016 Mar;75(3):526-31. doi: 10.1136/annrheumdis-2014-206897. Epub 2015 Mar 10.

20.

Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis.

Chan TM, Tse KC, Tang CS, Mok MY, Li FK; Hong Kong Nephrology Study Group.

J Am Soc Nephrol. 2005 Apr;16(4):1076-84. Epub 2005 Feb 23.

Supplemental Content

Support Center